search returned 100 results for adalimumab, showing results 1 to 10
, research and advocacy.
Adalimumab... Medication Information / A - B / Adalimumab...
Adalimumab
https://rheumatology.org.au/For-Patients/Adult-Medication-Information/A-B/Adalimumab
Wilson
Re: PBAC recommendation - adalimumab for paediatric immune-mediated
inflammatory diseases... deferred the decision to list adalimumab for immune-mediated
inflammatory diseases (IMID... of adalimumab in IMID in paediatric patients. As such
we are writing to offer our expertise to the PBAC
https://rheumatology.org.au/LinkClick.aspx?fileticket=4Z2czKWfqU8%3d
28 March 2025
PBAC Secretariat
Department of Health
GPO Box 9848
CANBERRA ACT 2601
Via email: pbac@health.gov.au
Dear PBAC secretariat
Thank you for the opportunity to comment/provide feedback on the draft PBS restrictions for
adalimumab for enthesitis
https://rheumatology.org.au/LinkClick.aspx?fileticket=HlV61HwKA0I%3d
28 March 2025
PBAC Secretariat
Department of Health
GPO Box 9848
CANBERRA ACT 2601
Via email: pbac@health.gov.au
Dear PBAC secretariat
Thank you for the opportunity to comment/provide feedback on the draft PBS restrictions for
adalimumab for enthesitis
https://rheumatology.org.au/LinkClick.aspx?fileticket=HlV61HwKA0I%3d&portalid=2
:
ADALIMUMAB - Humira®:Vision threatening non-infectious uveitis
8 How did you find out about... Scheme (PBS) listing of adalimumab for vision threatening non-infectious
uveitis (NIU). Rheumatologists... resistant NIU. Adalimumab is the most
closely studied bDMARD for NIU and multiple high quality randomised
https://rheumatology.org.au/LinkClick.aspx?fileticket=xiNvLmKnwVY%3d
Dr Barrett
Re: Adalimumab substitution
Thank you for your letter of 10 May 2021 concerning the substitution of adalimumab at the
pharmacy level. I referred the concerns raised and requests made... Executive will review
the available data on adalimumab substitution at the pharmacy level in order
https://rheumatology.org.au/LinkClick.aspx?fileticket=%2bOOViH6buSk%3d
PBS Therapeutic Update
PBAC Recommendations for adalimumab listing on the PBS... to the Pharmaceutical Benefts Scheme (PBS) listings for
adalimumab:
• new listing for enthesitis/spondylitis related... of the current PBS listings for adalimumab
for severe active JIA which include:
o reduced
https://rheumatology.org.au/LinkClick.aspx?fileticket=CI2sUSJ2vx4%3d
1
adalimumab
Revised July 2025
This information sheet is from the Australian... to monitor your
condition
• other precautions to take while you are
taking adalimumab.
Please read... is adalimumab?
Adalimumab belongs to a class of medicines
called biological disease modifying
https://rheumatology.org.au/LinkClick.aspx?fileticket=k3SjRLB0F44%3d
Professor Wilson
Re: Variation to indications for adalimumab in children with rheumatic...)
for variation to indications for adalimumab in children with rheumatic conditions.
As you are aware... and the extended Australian community.
The proposed variations will allow access to adalimumab in keeping
https://rheumatology.org.au/LinkClick.aspx?fileticket=fXQm9pr%2bYT4%3d
of adalimumab at the pharmacy level
With the introduction of several adalimumab biosimilars... of the biosimilar brand of
adalimumab at the community pharmacy level.
Specifically, we have received reports from patients where:
1. Pharmacists are refusing to stock the original brand of adalimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=Gc6suZkebsU%3d